Find my Gilead Sciences Inc 401(k) plan

Gilead Sciences Inc. is a biopharmaceutical company that focuses on research and development in the areas of unmet medical needs, including HIV/AIDS, liver disease, hematology/oncology, inflammation and other serious illnesses. Founded in 1987 as an antiviral drug discovery company, Gilead began developing products to treat infections caused by the human immunodeficiency virus (HIV). It rapidly grew to become one of the leading biotechnology companies specializing in HIV therapies worldwide. Over time, its efforts expanded into new areas of drug discovery and development with the mission of bringing life-saving treatments to patients around the world. In 2015, Gilead was named Fast Company’s 10th Most Innovative Biotech Company for its work advancing treatments for cancer and other conditions such as hepatitis C virus infection. Today under its core research areas which include cellular therapy as well as various drugs in clinical trials for nonalcoholic steatohepatitis (NASH), pulmonary arterial hypertension (PAH), heart failure and more - Gilead remains focused on creating medicines that can improve quality of life while making a real difference in patient care.